TY - JOUR T1 - Serious adverse events during a 6-min walk test in patients with pulmonary hypertension JF - European Respiratory Journal JO - Eur Respir J SP - 1179 LP - 1182 DO - 10.1183/09031936.00146914 VL - 45 IS - 4 AU - Norman R. Morris AU - Helen Seale AU - Julie Harris AU - Kathleen Hall AU - Peter Hopkins AU - Fiona Kermeen Y1 - 2015/04/01 UR - http://erj.ersjournals.com/content/45/4/1179.abstract N2 - The 6-min walk test (6MWT) is well standardised and, as per current guidelines, is deemed safe to perform in a range of patients [1]. In pulmonary arterial hypertension (PAH), 6-min walk distance (6MWD) is an important predictor of mortality and morbidity [2]. Moreover, changes in the 6MWD have been the primary end-point of most pivotal randomised controlled trials that have assessed the clinical response to specific pharmacological therapies in PAH [2].The first ever reported cases of serious adverse events during the 6MWT in patients with pulmonary hypertension http://ow.ly/FdVp8The authors would like to thank Associate Professor Anne Holland (La Trobe University, Melbourne, Australia) for her comments on this manuscript. ER -